Bank of New York Mellon’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.7M Sell
468,486
-12,900
-3% -$1.37M 0.01% 1003
2025
Q1
$59.8M Buy
481,386
+3,635
+0.8% +$451K 0.01% 853
2024
Q4
$58.8M Buy
477,751
+24,481
+5% +$3.01M 0.01% 904
2024
Q3
$50.5M Sell
453,270
-59,543
-12% -$6.63M 0.01% 1028
2024
Q2
$54.7M Sell
512,813
-47,982
-9% -$5.12M 0.01% 970
2024
Q1
$67.5M Sell
560,795
-19,229
-3% -$2.32M 0.01% 870
2023
Q4
$71.3M Sell
580,024
-39,875
-6% -$4.9M 0.01% 828
2023
Q3
$80.2M Sell
619,899
-1,978
-0.3% -$256K 0.02% 732
2023
Q2
$77.1M Sell
621,877
-10,110
-2% -$1.25M 0.02% 761
2023
Q1
$92.5M Sell
631,987
-18,143
-3% -$2.65M 0.02% 653
2022
Q4
$104M Buy
650,130
+203
+0% +$32.3K 0.02% 595
2022
Q3
$86.6M Buy
649,927
+47,501
+8% +$6.33M 0.02% 648
2022
Q2
$94M Buy
602,426
+23,253
+4% +$3.63M 0.02% 622
2022
Q1
$90.2M Sell
579,173
-12,607
-2% -$1.96M 0.02% 731
2021
Q4
$75.4M Sell
591,780
-10,862
-2% -$1.38M 0.01% 872
2021
Q3
$78.5M Sell
602,642
-20,569
-3% -$2.68M 0.02% 820
2021
Q2
$111M Buy
623,211
+22,553
+4% +$4.01M 0.02% 654
2021
Q1
$98.7M Buy
600,658
+10,632
+2% +$1.75M 0.02% 705
2020
Q4
$97.4M Sell
590,026
-3,636
-0.6% -$600K 0.02% 667
2020
Q3
$84.7M Buy
593,662
+298,814
+101% +$42.6M 0.02% 643
2020
Q2
$32.5M Sell
294,848
-18,694
-6% -$2.06M 0.01% 1149
2020
Q1
$31.3M Sell
313,542
-411,563
-57% -$41M 0.01% 1020
2019
Q4
$108M Sell
725,105
-42,201
-5% -$6.3M 0.03% 567
2019
Q3
$98.3M Sell
767,306
-188,898
-20% -$24.2M 0.03% 601
2019
Q2
$136M Sell
956,204
-328,606
-26% -$46.8M 0.04% 460
2019
Q1
$184M Sell
1,284,810
-160,671
-11% -$23M 0.05% 352
2018
Q4
$179M Sell
1,445,481
-244,904
-14% -$30.4M 0.06% 320
2018
Q3
$284M Buy
1,690,385
+207,954
+14% +$35M 0.07% 257
2018
Q2
$255M Sell
1,482,431
-142,460
-9% -$24.5M 0.07% 278
2018
Q1
$245M Sell
1,624,891
-135,656
-8% -$20.5M 0.07% 293
2017
Q4
$237M Buy
1,760,547
+274,121
+18% +$36.9M 0.06% 319
2017
Q3
$217M Buy
1,486,426
+105,838
+8% +$15.5M 0.06% 336
2017
Q2
$215M Sell
1,380,588
-67,172
-5% -$10.4M 0.06% 333
2017
Q1
$210M Buy
1,447,760
+44,973
+3% +$6.53M 0.06% 344
2016
Q4
$153M Buy
1,402,787
+236,568
+20% +$25.8M 0.04% 422
2016
Q3
$142M Sell
1,166,219
-66,834
-5% -$8.12M 0.04% 414
2016
Q2
$174M Buy
1,233,053
+49,967
+4% +$7.06M 0.05% 356
2016
Q1
$154M Buy
1,183,086
+86,219
+8% +$11.3M 0.05% 387
2015
Q4
$154M Buy
1,096,867
+70,119
+7% +$9.86M 0.05% 385
2015
Q3
$136M Sell
1,026,748
-87,618
-8% -$11.6M 0.04% 427
2015
Q2
$196M Sell
1,114,366
-33,295
-3% -$5.86M 0.05% 365
2015
Q1
$198M Buy
1,147,661
+568,476
+98% +$98.2M 0.05% 381
2014
Q4
$94.8M Buy
579,185
+65,796
+13% +$10.8M 0.02% 613
2014
Q3
$82.4M Buy
513,389
+261,281
+104% +$42M 0.02% 647
2014
Q2
$37.1M Sell
252,108
-17,113
-6% -$2.52M 0.01% 1075
2014
Q1
$37.3M Sell
269,221
-349,858
-57% -$48.5M 0.01% 1076
2013
Q4
$78.4M Sell
619,079
-78,810
-11% -$9.97M 0.02% 666
2013
Q3
$64.2M Sell
697,889
-51,335
-7% -$4.72M 0.02% 733
2013
Q2
$51.5M Buy
+749,224
New +$51.5M 0.02% 812